0000014272-16-000409.txt : 20160505 0000014272-16-000409.hdr.sgml : 20160505 20160505163125 ACCESSION NUMBER: 0000014272-16-000409 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160503 FILED AS OF DATE: 20160505 DATE AS OF CHANGE: 20160505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Caforio Giovanni CENTRAL INDEX KEY: 0001533201 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 161624303 MAIL ADDRESS: STREET 1: BRISTOL-MYERS SQUIBB COMPANY STREET 2: ROUTE 206 & PROVINCELINE ROAD CITY: LAWRENCEVILLE STATE: NJ ZIP: 08543 4 1 wf-form4_146248027193607.xml FORM 4 X0306 4 2016-05-03 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001533201 Caforio Giovanni BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 1 1 0 0 Chief Executive Officer Common Stock, $0.10 par value 2016-05-03 4 M 0 21615 27.01 A 132263.3365 D Common Stock, $0.10 par value 2016-05-03 4 S 0 15145 71.322 D 117118.3365 D Common Stock, $0.10 par value 2016-05-03 4 M 0 28840 23.12 A 145958.3365 D Common Stock, $0.10 par value 2016-05-03 4 S 0 19449 71.30 D 126509.3365 D Option (right to buy) 27.01 2016-05-03 4 M 0 21615 0 D 2017-03-05 Common Stock, $0.10 par value 21615.0 0 D Option (right to buy) 23.12 2016-05-03 4 M 0 28840 0 D 2018-03-03 Common Stock, $0.10 par value 28840.0 0 D These shares were sold to cover exercise price and taxes in accordance with broker's procedure for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $71.31 to $71.34, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. These shares were sold to cover exercise price and taxes in accordance with broker's procedure for sell-to-cover transactions. All of the shares are currently exercisable. /s/ Katherine Kelly, attorney-in-fact for Giovanni Caforio 2016-05-05